
Marrone Bio Innovations MBII
Quarterly report 2022-Q1
added 12-23-2023
Marrone Bio Innovations General and Administrative Expenses 2011-2025 | MBII
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Marrone Bio Innovations
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 30.6 M | 75 K | 30.1 M | 19.2 M | 19.8 M | 18.5 M | 26.5 M | 29 M | 15 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 30.6 M | 75 K | 21 M |
Quarterly General and Administrative Expenses Marrone Bio Innovations
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 10.1 M | - | 7.26 M | 7.29 M | 7.48 M | - | 7.34 M | 7.08 M | 7.99 M | - | 9.6 M | 6.6 M | 5.67 M | - | 4.16 M | 4.75 M | 5.03 M | - | 5.17 M | 5.07 M | 5.34 M | - | 3.75 M | 4.51 M | 5.53 M | - | 5.32 M | 7.41 M | 7.89 M | 9.31 M | 7.39 M | 5.92 M | 6.32 M | 4.53 M | 4.53 M | 3.12 M | 2.85 M | - | 2.62 M | 2.17 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 10.1 M | 2.17 M | 5.91 M |
General and Administrative Expenses of other stocks in the Agricultural inputs industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Акрон
AKRN
|
32.1 B | - | - | - | ||
|
Bioceres Crop Solutions Corp.
BIOX
|
47.6 M | $ 1.56 | -0.64 % | $ 435 M | ||
|
ФосАгро
PHOR
|
6.93 B | - | - | - | ||
|
China Green Agriculture
CGA
|
24.4 M | - | 0.51 % | $ 27.6 M | ||
|
CF Industries Holdings
CF
|
320 M | $ 78.57 | -0.81 % | $ 14.2 B | ||
|
ICL Group Ltd
ICL
|
276 M | $ 4.97 | -2.07 % | $ 7.83 B | ||
|
FMC Corporation
FMC
|
645 M | $ 13.09 | -5.86 % | $ 1.64 B | ||
|
Corteva
CTVA
|
3.2 B | $ 65.62 | -0.68 % | $ 45.5 B | ||
|
American Vanguard Corporation
AVD
|
120 M | $ 4.05 | -6.14 % | $ 114 M | ||
|
Nutrien Ltd.
NTR
|
477 M | $ 61.9 | -1.57 % | $ 34.8 B | ||
|
Intrepid Potash
IPI
|
33 M | $ 26.77 | -1.29 % | $ 345 M | ||
|
The Mosaic Company
MOS
|
497 M | $ 24.95 | -4.84 % | $ 7.98 B | ||
|
Yield10 Bioscience
YTEN
|
6.15 M | - | 15.32 % | $ 46.6 M | ||
|
Arcadia Biosciences
RKDA
|
14.5 M | $ 3.7 | 1.65 % | $ 4.58 M | ||
|
Origin Agritech Limited
SEED
|
73.3 M | $ 1.32 | -8.33 % | $ 7.42 M | ||
|
The Scotts Miracle-Gro Company
SMG
|
603 M | $ 58.34 | 1.08 % | $ 3.36 B | ||
|
CVR Partners, LP
UAN
|
28.4 M | $ 95.49 | 0.14 % | $ 1.01 B |